Gastric cancer is the fifth most frequently diagnosed malignant neoplasm and the third
leading cause of cancer-related mortality. Nevertheless, the therapeutic efficacy of …

Digestive tract cancers (DTC) belong to the most investigated family of tumors. The
incidence, prevalence, and mortality rate of DTC remain high, especially for patients with …

Background Women with cervical cancer constitute a patient population in need for ongoing,
person-centred supportive care. Our aim was to synthesise current available evidence with …

Background Currently available prognostic tools and focused therapeutic methods result in
unsatisfactory treatment of gastric cancer (GC). A deeper understanding of human epidermal …

Baicalein is a natural flavonoid with various pharmacological activities including antitumor.
The synergistic anti-cancer effect of the combination of baicalein and Cisplatin (DDP) on …

This study investigates the association of PD-L1 expression and immune cell infiltrates and
their impact on clinical outcome, in addition to their overlap with microsatellite instability …

Introduction: Apatinib, a small-molecule inhibitor of vascular endothelial growth factor
receptor 2, has demonstrated encouraging anti-cancer activity in gastric cancer within both …

Abstract Dual‑specificity phosphatase‑1 (DUSP1) is an oncogene that is associated with
cancer progression following drug resistance. In order to investigate the potential …

Gastric cancer remains the third leading cause of cancer-related mortality worldwide, and
invasion and metastasis of gastric cancer represent the major reason for its poor prognosis …

Cancer therapy utilizing adoptive transfer of chimeric antigen receptor (CAR) T cells has
demonstrated remarkable clinical outcomes in hematologic malignancies. However, CAR T …